Raleigh drugmaker slashes workforce as biotech downturn deepens
- Oops!Something went wrong.Please try again later.
- RDHL
The drugmaker is cutting one-third of its U.S. commercial workforce as part of a plan to save $50 million. The move comes as the biotech industry sees cuts across the board as the highs of the pandemic fade away.